Why the study?
Existing prognostic biomarkers are not effective in all patients with acute aortic dissection, and the prognostic value of serum C-reactive protein levels in this population remains unclear.
Does admission C-reactive protein level predict in-hospital mortality in patients with type-A acute aortic dissection?
Does admission C-reactive protein level predict in-hospital mortality in patients with type-A acute aortic dissection?
Elevated admission C-reactive protein is a significant predictor of in-hospital mortality in patients with type-A acute aortic dissection.
Answers are grounded in this paper and cite their sources.
May refine mortality risk stratification in type-A aortic dissection; leaves open need for prospective validation before practice change.
BACKGROUND: Acute aortic dissection (AD) is a lethal vascular disease, accounting for over 90% cases of acute aortic syndrome. Despite advances in understanding associated risk factors, the long-term prognosis for AD patients is still poor. Several prognostic biomarkers have been used for AD as per the IRAD, such as older age (>70 years), onset of chest pain and hypotension, but they are not effective in all patients. Instead, C-reactive protein (CRP) is a consistent inflammatory marker. CRP levels are abnormally increased in AD. However, the prognostic value of serum CRP level in AD remains unclear. OBJECTIVE: To perform a systematic review and meta-analysis (registration no CRD42017056205) to evaluate whether CRP is a biomarker associated with in-hospital mortality in type-A AD. METHODS: PubMed, Web of Science, CNKI, SciELO, and EMBASE were searched for papers published from January 2000 to October 2017 for studies on the prognostic role of CRP at admission in type-A AD patients. Outcome data were extracted and pooled hazard ratios (HRs) were calculated. CONCLUSION: Elevated CRP level is significantly associated with increased risks of in-hospital mortality in patients with type-A AD. CRP is a convenient prognostic factor in type-A AD patients.
No takes yet. Share an insight, caveat, or question.
Wc et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: